Genetics of Both Virus and Patient Work Together to Influence the Course of HIV Infection
Viral and human genetics together account for about one third of the differences in disease progression rates seen among people infected with the human immunodeficiency virus (HIV), according to new research published in PLOS Computational Biology. The findings suggest that patient genetics influences disease progression by triggering mutations in the HIV viral genome.
HIV, the AIDS virus (yellow), infecting a human cell. Courtesy of ZEISS Microscopy/Flickr
Viral and human genetics together account for about one third of the differences in disease progression rates seen among people infected with the human immunodeficiency virus (HIV), according to new research published in PLOS Computational Biology. The findings suggest that patient genetics influences disease progression by triggering mutations in the HIV viral genome.
People with HIV experience different rates of disease progression. HIV progresses faster in people with a higher viral load--the amount of genetic material from the HIV virus found in an infected person's blood.
Previous research has shown that an infected person's genetics and the genetics of their particular HIV strain both influence viral load. István Bartha of École Polytechnique Fédérale de Lausanne, Switzerland, and colleagues are now the first scientists to investigate the relative impacts of human and viral genetics on viral load within the same group of patients.
The researchers collected patient and viral genetic data from 541 people with HIV. They used a computational modeling method known as linear mixed modeling to determine how human and viral genetics might explain differences in viral load between the patients.
They found that genetic differences between HIV strains explain 29 percent of differences in viral load between patients, while human genetic variation explains 8.4 percent. Together, they explain just 30 percent of viral load variation, indicating that patient genetics exert most of its influence by inducing genetic mutations in the HIV virus as it multiplies inside the patient.
"Our paper demonstrates that the genetic make-up of both the patient and the infecting virus contribute to the clinical course of HIV infection," says study director Jacques Fellay.
Further research with a larger group of patients is needed to confirm and refine the findings. Nonetheless, "combining host and pathogen data gave us new insight into the genetic determinants of HIV control," Fellay says. "A similar strategy could be used to better understand other chronic infectious diseases."
Reference: Bartha I, McLaren PJ, Brumme C, Harrigan R, Telenti A, Fellay J (2017) Estimating the Respective Contributions of Human and Viral Genetic Variation to HIV Control. PLoS Comput Biol 13(2): e1005339. doi:10.1371/journal.pcbi.1005339
Source: PLOS
CDC Urges Vigilance: New Recommendations for Monitoring and Testing H5N1 Exposures
July 11th 2025With avian influenza A(H5N1) infections surfacing in both animals and humans, the CDC has issued updated guidance calling for aggressive monitoring and targeted testing to contain the virus and protect public health.
IP LifeLine: Layoffs and the Evolving Job Market Landscape for Infection Preventionists
July 11th 2025Infection preventionists, once hailed as indispensable during the pandemic, now face a sobering reality: budget pressures, hiring freezes, and layoffs are reshaping the field, leaving many IPs worried about their future and questioning their value within health care organizations.
A Helping Hand: Innovative Approaches to Expanding Hand Hygiene Programs in Acute Care Settings
July 9th 2025Who knew candy, UV lights, and a college kid in scrubs could double hand hygiene adherence? A Pennsylvania hospital’s creative shake-up of its infection prevention program shows that sometimes it takes more than soap to get hands clean—and keep them that way.
